Skip to main content
SRTS logo

SRTS · Sensus Healthcare, Inc. · Executive Compensation

Track SRTS — free
$2.36 +0.06 (+2.61%) At close · Nov 19 Play latest call Q3 2026 earnings call transcript
Market Cap
$38.85M
Shares
16.46M
Volume · Nov 19 170.43K Avg daily vol (3M) 205.66K

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Joseph Sardano $1,417,860
Michael Sardano $1,213,917
Javier Rampolla $752,710
Fiscal 2024
Executive Total
Michael Sardano $1,275,078
Joseph Sardano $1,268,030
Javier Rampolla $656,045
Fiscal 2023
Executive Total
Joseph Sardano $687,599
Michael Sardano $452,523
Javier Rampolla $357,062
Fiscal 2022
Executive Total
Joseph Sardano $754,428
Javier Rampolla $439,144
Michael Sardano $404,739
Fiscal 2021
Executive Total
Joseph Sardano $628,451
Javier Rampolla $430,732
Michael Sardano $426,973
Stephen Cohen $409,382
Fiscal 2020
Executive Total
Joseph Sardano $510,006
Stephen Cohen $435,737
Michael Sardano $261,072
Fiscal 2019
Executive Total
Stephen Cohen $521,260
Joseph Sardano $466,800
Arthur Levine $284,448
Michael Sardano $228,859
Fiscal 2018
Executive Total
Arthur Levine $584,600
Joseph Sardano $538,392
Stephen Cohen $478,617

Executive changes

Person Change Filed
Larry Biscotti Appointed 2026-01-12
Eric Sachetta Appointed 2025-11-13
Dr. John Heinrich
“To the knowledge of the Company’s executive officers, Dr. Heinrich’s decision to resign was not the result of any disagreement between Dr. Heinrich and the Registrant that would require disclosure under Item 5.02(a) of Form 8-K.”
Resigned 2024-05-31
Samuel O'Rear
“Mr. O’Rear’s decision to retire was not the result of any disagreement between Mr. O’Rear and the Company that would require disclosure under Item 5.02(a) of Form 8-K.”
Retired 2024-02-02
Michael Sardano Appointed 2024-01-18
Javier Rampolla Appointed 2023-06-06
Magdalena Martinez Appointed 2023-01-09
Stephen Cohen Resigned 2022-01-31
Joseph C. Sardano Resigned 2022-01-31
Michael J. Sardano Appointed 2022-01-31

Leadership

Key facts CIK 1494891 CUSIP 81728J109 13F (30d) 42 filings 36 filers Visit website Investor relations